In this interview at ISPOR Europe 2019, Daniel Mullins (University of Maryland, MD, USA) discusses the importance, benefits and challenges of engaging patients in comparative effectiveness research. He explains how clinical trials should be fundamentally aimed at improving patient care and should allow them to make informed decisions about their treatments.
About the author:
Daniel Mullins is professor and chair of the Pharmaceutical Health Services Research Department at the University of Maryland School of Pharmacy. His overarching goal is focused on incorporating patient engagement into research, while focusing on comparative effectiveness, patient-centered outcomes, pharmacoeconomics, and health disparities research. He directs the University of Maryland PATient-centered Involvement in Evaluating effectiveNess of TreatmentS (PATIENTS) Program, which aims to empower patients and stakeholders in R&D.
Video originally published on The Evidence Base, a digital platform from the Future Science Group covering the latest news, opinion and insight into the collection and application of real-world data to real-world problems.